EDOC


Telemedicine & Digital Health ETF

Reasons to Consider EDOC

High Growth Potential

The global telemedicine market increased over 6% from 2021 to 2022, exceeding $75bn. Forecasts suggest the market could reach over $200bn by 2027.1

Structural Tailwinds

In 2019, an estimated half of the global population lacked essential health care services.2 As more underserved markets gain broadband access, telemedicine offers vast opportunity to bridge the divide.

New Consumer Preferences

The pandemic increased adoption of digital health services, with many turning to telemedicine for the first time, accelerating the theme’s reach.

1Statista, Dec 2022
2World Economic Forum

Key Information As of 03/23/23

Inception Date 07/29/20
Total Expense Ratio 0.68%
Net Assets $133.62 million
NAV $11.57
Fact Sheet

ETF Summary

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to invest in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.

ETF Objective

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.

Trading Details As of 03/23/23

Ticker EDOC
Bloomberg Index Ticker SOLEDOC
CUSIP 37954Y285
ISIN US37954Y2853
Primary Exchange Nasdaq
Shares Outstanding 11,550,000
Number of Holdings 39
30-Day Median Bid-Ask Spread 0.51%

Distributions As of 03/23/23

30-Day SEC Yield 0.13%
Distribution Frequency Semi-Annually

ETF Prices As of 03/23/23

NAV $11.57 Daily Change $0.03 0.26%
Market Price $11.52 Daily Change -$0.07 -0.60%

Performance History

As of recent
(12/31/22)
As of recent
(12/31/22)
Fund NAV Market Price Index
1 Year -29.43% -29.99% -29.07%
Since Inception -10.36% -10.67% -9.85%
1 Year -18.91% -19.20% -18.84%
Since Inception -9.53% -9.80% -9.17%
Year-to-Date -29.43% -29.99% -29.07%
1 Month -4.50% -5.08% -4.46%
3 Months 3.18% 2.48% 3.77%
Since Inception -23.28% -23.94% -22.24%
Year-to-Date 0.60% 0.69% 0.28%
1 Month -6.00% -6.65% -6.31%
3 Months -3.92% -4.43% -4.20%
Since Inception -22.82% -23.42% -22.02%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 03/23/23

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
6.23 241 HK ALIBABA HEALTH BRXVS60 0.78 10,565,100 8,290,892.14
5.91 6618 HK JD HEALTH INTERN BMW8R04 8.01 981,650 7,866,005.71
5.46 MASI MASIMO CORP B1YWR63 174.42 41,668 7,267,732.56
5.29 DOCS DOXIMITY INC-CLASS A BMD22Y4 32.91 213,663 7,031,649.33
4.70 DXCM DEXCOM INC B0796X4 114.50 54,632 6,255,364.00
4.04 IRTC IRHYTHM TECHNOLOGIES INC BYT4ST5 119.23 45,085 5,375,484.55
4.01 A AGILENT TECHNOLOGIES INC 2520153 131.13 40,711 5,338,433.43
3.94 LH LABORATORY CP 2586122 214.65 24,388 5,234,884.20
3.90 RMD AU RESMED INC-CDI 6221667 21.27 243,862 5,185,868.83
3.85 ILMN ILLUMINA INC 2613990 216.95 23,616 5,123,491.20
3.82 TDOC TELADOC HEALTH INC BYQRFY1 24.23 209,628 5,079,286.44
3.65 UNH UNITEDHEALTH GROUP INC 2917766 469.91 10,325 4,851,820.75
3.51 SGFY SIGNIFY HEALTH-A BMD8TD0 28.90 161,701 4,673,158.90
3.31 RCM R1 RCM INC BP2S437 13.75 320,466 4,406,407.50
3.18 PACB PACIFIC BIOSCIEN B4N8MH9 9.24 457,383 4,226,218.92
3.15 TNDM TANDEM DIABETES CARE INC BF3W461 41.73 100,507 4,194,157.11
3.04 OMCL OMNICELL INC 2789523 56.02 72,266 4,048,341.32
2.90 AMN AMN HEALTHCARE 2813552 82.70 46,690 3,861,263.00
2.65 VCYT VERACYTE INC BFTWZY0 22.12 159,079 3,518,827.48
2.59 PHR PHREESIA INC BKF9DQ8 30.99 111,192 3,445,840.08
2.37 COP GR COMPUGROUP MEDIC BMY7CH1 51.10 61,624 3,148,745.01
2.35 MDRX VERADIGM INC 2710039 12.89 242,811 3,129,833.79
2.20 1833 HK PING AN HEALTHCA BDRYVB3 2.69 1,086,300 2,919,975.29
1.69 HIMS HIMS & HERS HEALTH INC BN46048 9.41 238,640 2,245,602.40
1.55 NXGN NEXTGEN HEALTHCARE INC BF5L3D6 16.69 123,239 2,056,858.91
1.48 TWST TWIST BIOSCIENCE CORP BGKG6G7 15.98 122,909 1,964,085.82
1.16 DCGO DOCGO INC BKP4P23 8.73 176,329 1,539,352.17
1.11 4480 JP MEDLEY INC BK93ZN7 33.17 44,489 1,475,664.76
1.05 SHCR SHARECARE INC BJL95B4 2.19 637,649 1,396,451.31
0.82 LFST LIFESTANCE HEALT BN0TRB7 7.07 155,102 1,096,571.14
0.77 AMWL AMERICAN WELL -A BN0SDK5 2.24 458,548 1,027,147.52
0.76 GDRX GOODRX HOLDIN-A BMTVQT8 6.42 156,804 1,006,681.68
0.67 CPSI COMPUTER PROGRAM 2872122 28.27 31,606 893,501.62
0.56 DH DEFINITIVE HEALT BMGSDK2 10.61 70,312 746,010.32
0.52 BNGO BIONANO GENOMICS INC BFY8K60 1.09 639,979 697,577.11
0.50 NVTA INVITAE CORP BVVCNT1 1.28 518,557 663,752.96
0.49 SENS SENSEONICS HOLDINGS INC BYQNYR5 0.72 913,377 654,160.61
0.39 OPRX OPTIMIZERX CORP BF5MM09 14.03 37,182 521,663.46
0.25 HLTH CUE HEALTH INC BM9J045 1.80 186,535 335,763.00
0.18 CASH 1.00 244,950 244,950.26
0.00 EURO 1.09 10 10.56
0.00 HONG KONG DOLLAR 0.13 4 0.51
Holdings are subject to change. "Cash" denotes U.S. dollars.

Sector Breakdown As of 02/28/23

Sector Weight (%)
Health Care 93.1
Consumer Discretionary 5.1
Financials 1.2
Information Technology 0.6

Source: AltaVista Research, LLC

Country Breakdown As of 02/28/23

Country Weight (%)
United States 84.3
China 6.9
Hong Kong 5.6
Germany 2.2
Japan 1.0

Source: AltaVista Research, LLC

ETF Characteristics As of 03/23/23

Return on Equity -1.70%
Weighted Avg. Market Cap 28,296 M
2022 2023
Price-to-earnings -6.40 -170.97
Price-to-book value 2.85 2.93

Source: AltaVista Research, LLC

ETF Risk Stats As of 02/28/23

Versus Beta
S&P 500 0.87
MSCI EAFE 0.84
MSCI Emg. Mkts 0.77
Standard Deviation 22.40%

Source: AltaVista Research, LLC

ETF Research

View More Related Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which EDOC may invest may be limited. The Fund invests in securities of companies engaged in the Health Care and Information Technology sectors. These sectors can be affected by government regulations, rapid product obsolescence, intense industry competition and loss or impairment of patents or intellectual property rights. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. EDOC is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Solactive AG, nor does Solactive AG make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Solactive AG.

Back to Top